Main Industry
Biotechnology
Main Product/Service
Next-Generation DNA Synthesis: Development of next-generation enzymatic DNA and RNA synthesis reagents and technology platforms, rapid nucleic acid labeling platforms, and biomedical and biotechnology applications.
The content above was translated by Ai
Founded Year
2019
Unified Business No.
54978743
Status
Active
Number of Employees
0
Total Paid-in
Capital
165,145,986 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Yuan-Dian Biotechnology is dedicated to the development of next-generation DNA synthesis (Next-Generation DNA Synthesis) technologies and platforms. We create applications for DNA in the biotechnology and biomedical industries through innovations in basic science. Yuan-Dian Biotech has broken through the highly challenging bottlenecks of traditional chemical DNA synthesis technology, establishing and validating a new generation of enzymatic DNA synthesis (Enzymatic DNA Synthesis) technology and platform. This technology and platform will greatly improve the efficiency and cost of current oligonucleotide and probe synthesis (oligonucleotide & Probe Synthesis), making DNA reading (Sequencing) and writing (Synthesis) faster and more accessible. The extension of this technology will accelerate innovations in personalized precision medicine, the development of novel nucleic acid and protein vaccines, gene editing and the improvement of animal and plant genomes, applications of synthetic biology, and even the commercialization of DNA-based big data storage and computing. The resulting industrial transformation will span healthcare, biotechnology, agriculture, energy, information technology, and more.
The content above was translated by Ai
